Clinical Trial

Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Name: Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer — clinical trial record (NCT07314203)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SOP-XH-IRB

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Exploring the pathological complete response rate (pCR) of locally advanced gastric cancer treated with adebelimab combined or not combined with apatinib mesylate and SOX neoadjuvant therapy

Trial Details

NCT Number	NCT07314203
Lead Sponsor	Fujian Medical University
Conditions	Gastric Cancer, Surgery
Enrollment	118 participants
Start Date	2026-12-25
Primary Completion	2027-08-25 (estimated)
Study Completion	2028-08-25 (estimated)
Updated on ClinicalTrials.gov	2026-01-02